ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Histone Deacetylase (HDAC) Inhibitors Market Research Report 2025
Published Date: January 2025
|
Report Code: QYRE-Auto-29M9158
Home | Market Reports | Science
Global Histone Deacetylase HDAC Inhibitors Market Insights and Forecast to 2028
BUY CHAPTERS

Global Histone Deacetylase (HDAC) Inhibitors Market Research Report 2025

Code: QYRE-Auto-29M9158
Report
January 2025
Pages:97
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
4SC AG
Acetylon Pharmaceuticals
Celleron Therapeutics
Chipscreen Biosciences
Chroma Therapeutics
CrystalGenomics Inc
Curis
MEI Pharma
Mirati Therapeutics
Novartis
Onxeo
Repligen
TetraLogic

Histone Deacetylase (HDAC) Inhibitors Market Size

The global market for Histone Deacetylase (HDAC) Inhibitors was valued at US$ 740 million in the year 2024 and is projected to reach a revised size of US$ 1320 million by 2031, growing at a CAGR of 8.8% during the forecast period.

Histone Deacetylase (HDAC) Inhibitors Market

Histone Deacetylase (HDAC) Inhibitors Market

North American market for Histone Deacetylase (HDAC) Inhibitors is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Histone Deacetylase (HDAC) Inhibitors is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Histone Deacetylase (HDAC) Inhibitors include 4SC, Acetylon Pharmaceuticals, Celleron Therapeutics, Chipscreen Biosciences, Chroma Therapeutics, CrystalGenomics, Curis, MEI Pharma, Mirati Therapeutics, Novartis, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Histone Deacetylase (HDAC) Inhibitors, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Histone Deacetylase (HDAC) Inhibitors.
The Histone Deacetylase (HDAC) Inhibitors market size, estimations, and forecasts are provided in terms of sales volume (MT) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Histone Deacetylase (HDAC) Inhibitors market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Histone Deacetylase (HDAC) Inhibitors manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Histone Deacetylase (HDAC) Inhibitors Market Report

Report Metric Details
Report Name Histone Deacetylase (HDAC) Inhibitors Market
Accounted market size in year US$ 740 million
Forecasted market size in 2031 US$ 1320 million
CAGR 8.8%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company 4SC, Acetylon Pharmaceuticals, Celleron Therapeutics, Chipscreen Biosciences, Chroma Therapeutics, CrystalGenomics, Curis, MEI Pharma, Mirati Therapeutics, Novartis, Onxeo, Repligen, TetraLogic
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Histone Deacetylase (HDAC) Inhibitors manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Histone Deacetylase (HDAC) Inhibitors in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Histone Deacetylase (HDAC) Inhibitors Market growing?

Ans: The Histone Deacetylase (HDAC) Inhibitors Market witnessing a CAGR of 8.8% during the forecast period 2025-2031.

What is the Histone Deacetylase (HDAC) Inhibitors Market size in 2031?

Ans: The Histone Deacetylase (HDAC) Inhibitors Market size in 2031 will be US$ 1320 million.

Who are the main players in the Histone Deacetylase (HDAC) Inhibitors Market report?

Ans: The main players in the Histone Deacetylase (HDAC) Inhibitors Market are 4SC, Acetylon Pharmaceuticals, Celleron Therapeutics, Chipscreen Biosciences, Chroma Therapeutics, CrystalGenomics, Curis, MEI Pharma, Mirati Therapeutics, Novartis, Onxeo, Repligen, TetraLogic

What are the Application segmentation covered in the Histone Deacetylase (HDAC) Inhibitors Market report?

Ans: The Applications covered in the Histone Deacetylase (HDAC) Inhibitors Market report are Treatment of Malignant Tumors, Chronic Disease Treatment, Others

What are the Type segmentation covered in the Histone Deacetylase (HDAC) Inhibitors Market report?

Ans: The Types covered in the Histone Deacetylase (HDAC) Inhibitors Market report are Fatty Acid, Hydroxamate, Cyclic Peptide, Benzamide

Recommended Reports

Oncology Inhibitors

Epigenetics & Related

Cancer Therapy Innovations

1 Histone Deacetylase (HDAC) Inhibitors Market Overview
1.1 Product Definition
1.2 Histone Deacetylase (HDAC) Inhibitors by Type
1.2.1 Global Histone Deacetylase (HDAC) Inhibitors Market Value Comparison by Type (2024 VS 2031)
1.2.2 Fatty Acid
1.2.3 Hydroxamate
1.2.4 Cyclic Peptide
1.2.5 Benzamide
1.3 Histone Deacetylase (HDAC) Inhibitors by Application
1.3.1 Global Histone Deacetylase (HDAC) Inhibitors Market Value by Application (2024 VS 2031)
1.3.2 Treatment of Malignant Tumors
1.3.3 Chronic Disease Treatment
1.3.4 Others
1.4 Global Histone Deacetylase (HDAC) Inhibitors Market Size Estimates and Forecasts
1.4.1 Global Histone Deacetylase (HDAC) Inhibitors Revenue 2020-2031
1.4.2 Global Histone Deacetylase (HDAC) Inhibitors Sales 2020-2031
1.4.3 Global Histone Deacetylase (HDAC) Inhibitors Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Histone Deacetylase (HDAC) Inhibitors Market Competition by Manufacturers
2.1 Global Histone Deacetylase (HDAC) Inhibitors Sales Market Share by Manufacturers (2020-2025)
2.2 Global Histone Deacetylase (HDAC) Inhibitors Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Histone Deacetylase (HDAC) Inhibitors Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Histone Deacetylase (HDAC) Inhibitors, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Histone Deacetylase (HDAC) Inhibitors, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Histone Deacetylase (HDAC) Inhibitors, Product Type & Application
2.7 Global Key Manufacturers of Histone Deacetylase (HDAC) Inhibitors, Date of Enter into This Industry
2.8 Global Histone Deacetylase (HDAC) Inhibitors Market Competitive Situation and Trends
2.8.1 Global Histone Deacetylase (HDAC) Inhibitors Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Histone Deacetylase (HDAC) Inhibitors Players Market Share by Revenue
2.8.3 Global Histone Deacetylase (HDAC) Inhibitors Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Histone Deacetylase (HDAC) Inhibitors Market Scenario by Region
3.1 Global Histone Deacetylase (HDAC) Inhibitors Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Histone Deacetylase (HDAC) Inhibitors Sales by Region: 2020-2031
3.2.1 Global Histone Deacetylase (HDAC) Inhibitors Sales by Region: 2020-2025
3.2.2 Global Histone Deacetylase (HDAC) Inhibitors Sales by Region: 2026-2031
3.3 Global Histone Deacetylase (HDAC) Inhibitors Revenue by Region: 2020-2031
3.3.1 Global Histone Deacetylase (HDAC) Inhibitors Revenue by Region: 2020-2025
3.3.2 Global Histone Deacetylase (HDAC) Inhibitors Revenue by Region: 2026-2031
3.4 North America Histone Deacetylase (HDAC) Inhibitors Market Facts & Figures by Country
3.4.1 North America Histone Deacetylase (HDAC) Inhibitors Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Histone Deacetylase (HDAC) Inhibitors Sales by Country (2020-2031)
3.4.3 North America Histone Deacetylase (HDAC) Inhibitors Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Histone Deacetylase (HDAC) Inhibitors Market Facts & Figures by Country
3.5.1 Europe Histone Deacetylase (HDAC) Inhibitors Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Histone Deacetylase (HDAC) Inhibitors Sales by Country (2020-2031)
3.5.3 Europe Histone Deacetylase (HDAC) Inhibitors Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Histone Deacetylase (HDAC) Inhibitors Market Facts & Figures by Region
3.6.1 Asia Pacific Histone Deacetylase (HDAC) Inhibitors Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Histone Deacetylase (HDAC) Inhibitors Sales by Region (2020-2031)
3.6.3 Asia Pacific Histone Deacetylase (HDAC) Inhibitors Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Histone Deacetylase (HDAC) Inhibitors Market Facts & Figures by Country
3.7.1 Latin America Histone Deacetylase (HDAC) Inhibitors Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Histone Deacetylase (HDAC) Inhibitors Sales by Country (2020-2031)
3.7.3 Latin America Histone Deacetylase (HDAC) Inhibitors Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Histone Deacetylase (HDAC) Inhibitors Market Facts & Figures by Country
3.8.1 Middle East and Africa Histone Deacetylase (HDAC) Inhibitors Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Histone Deacetylase (HDAC) Inhibitors Sales by Country (2020-2031)
3.8.3 Middle East and Africa Histone Deacetylase (HDAC) Inhibitors Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Histone Deacetylase (HDAC) Inhibitors Sales by Type (2020-2031)
4.1.1 Global Histone Deacetylase (HDAC) Inhibitors Sales by Type (2020-2025)
4.1.2 Global Histone Deacetylase (HDAC) Inhibitors Sales by Type (2026-2031)
4.1.3 Global Histone Deacetylase (HDAC) Inhibitors Sales Market Share by Type (2020-2031)
4.2 Global Histone Deacetylase (HDAC) Inhibitors Revenue by Type (2020-2031)
4.2.1 Global Histone Deacetylase (HDAC) Inhibitors Revenue by Type (2020-2025)
4.2.2 Global Histone Deacetylase (HDAC) Inhibitors Revenue by Type (2026-2031)
4.2.3 Global Histone Deacetylase (HDAC) Inhibitors Revenue Market Share by Type (2020-2031)
4.3 Global Histone Deacetylase (HDAC) Inhibitors Price by Type (2020-2031)
5 Segment by Application
5.1 Global Histone Deacetylase (HDAC) Inhibitors Sales by Application (2020-2031)
5.1.1 Global Histone Deacetylase (HDAC) Inhibitors Sales by Application (2020-2025)
5.1.2 Global Histone Deacetylase (HDAC) Inhibitors Sales by Application (2026-2031)
5.1.3 Global Histone Deacetylase (HDAC) Inhibitors Sales Market Share by Application (2020-2031)
5.2 Global Histone Deacetylase (HDAC) Inhibitors Revenue by Application (2020-2031)
5.2.1 Global Histone Deacetylase (HDAC) Inhibitors Revenue by Application (2020-2025)
5.2.2 Global Histone Deacetylase (HDAC) Inhibitors Revenue by Application (2026-2031)
5.2.3 Global Histone Deacetylase (HDAC) Inhibitors Revenue Market Share by Application (2020-2031)
5.3 Global Histone Deacetylase (HDAC) Inhibitors Price by Application (2020-2031)
6 Key Companies Profiled
6.1 4SC
6.1.1 4SC Company Information
6.1.2 4SC Description and Business Overview
6.1.3 4SC Histone Deacetylase (HDAC) Inhibitors Sales, Revenue and Gross Margin (2020-2025)
6.1.4 4SC Histone Deacetylase (HDAC) Inhibitors Product Portfolio
6.1.5 4SC Recent Developments/Updates
6.2 Acetylon Pharmaceuticals
6.2.1 Acetylon Pharmaceuticals Company Information
6.2.2 Acetylon Pharmaceuticals Description and Business Overview
6.2.3 Acetylon Pharmaceuticals Histone Deacetylase (HDAC) Inhibitors Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Acetylon Pharmaceuticals Histone Deacetylase (HDAC) Inhibitors Product Portfolio
6.2.5 Acetylon Pharmaceuticals Recent Developments/Updates
6.3 Celleron Therapeutics
6.3.1 Celleron Therapeutics Company Information
6.3.2 Celleron Therapeutics Description and Business Overview
6.3.3 Celleron Therapeutics Histone Deacetylase (HDAC) Inhibitors Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Celleron Therapeutics Histone Deacetylase (HDAC) Inhibitors Product Portfolio
6.3.5 Celleron Therapeutics Recent Developments/Updates
6.4 Chipscreen Biosciences
6.4.1 Chipscreen Biosciences Company Information
6.4.2 Chipscreen Biosciences Description and Business Overview
6.4.3 Chipscreen Biosciences Histone Deacetylase (HDAC) Inhibitors Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Chipscreen Biosciences Histone Deacetylase (HDAC) Inhibitors Product Portfolio
6.4.5 Chipscreen Biosciences Recent Developments/Updates
6.5 Chroma Therapeutics
6.5.1 Chroma Therapeutics Company Information
6.5.2 Chroma Therapeutics Description and Business Overview
6.5.3 Chroma Therapeutics Histone Deacetylase (HDAC) Inhibitors Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Chroma Therapeutics Histone Deacetylase (HDAC) Inhibitors Product Portfolio
6.5.5 Chroma Therapeutics Recent Developments/Updates
6.6 CrystalGenomics
6.6.1 CrystalGenomics Company Information
6.6.2 CrystalGenomics Description and Business Overview
6.6.3 CrystalGenomics Histone Deacetylase (HDAC) Inhibitors Sales, Revenue and Gross Margin (2020-2025)
6.6.4 CrystalGenomics Histone Deacetylase (HDAC) Inhibitors Product Portfolio
6.6.5 CrystalGenomics Recent Developments/Updates
6.7 Curis
6.7.1 Curis Company Information
6.7.2 Curis Description and Business Overview
6.7.3 Curis Histone Deacetylase (HDAC) Inhibitors Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Curis Histone Deacetylase (HDAC) Inhibitors Product Portfolio
6.7.5 Curis Recent Developments/Updates
6.8 MEI Pharma
6.8.1 MEI Pharma Company Information
6.8.2 MEI Pharma Description and Business Overview
6.8.3 MEI Pharma Histone Deacetylase (HDAC) Inhibitors Sales, Revenue and Gross Margin (2020-2025)
6.8.4 MEI Pharma Histone Deacetylase (HDAC) Inhibitors Product Portfolio
6.8.5 MEI Pharma Recent Developments/Updates
6.9 Mirati Therapeutics
6.9.1 Mirati Therapeutics Company Information
6.9.2 Mirati Therapeutics Description and Business Overview
6.9.3 Mirati Therapeutics Histone Deacetylase (HDAC) Inhibitors Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Mirati Therapeutics Histone Deacetylase (HDAC) Inhibitors Product Portfolio
6.9.5 Mirati Therapeutics Recent Developments/Updates
6.10 Novartis
6.10.1 Novartis Company Information
6.10.2 Novartis Description and Business Overview
6.10.3 Novartis Histone Deacetylase (HDAC) Inhibitors Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Novartis Histone Deacetylase (HDAC) Inhibitors Product Portfolio
6.10.5 Novartis Recent Developments/Updates
6.11 Onxeo
6.11.1 Onxeo Company Information
6.11.2 Onxeo Description and Business Overview
6.11.3 Onxeo Histone Deacetylase (HDAC) Inhibitors Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Onxeo Histone Deacetylase (HDAC) Inhibitors Product Portfolio
6.11.5 Onxeo Recent Developments/Updates
6.12 Repligen
6.12.1 Repligen Company Information
6.12.2 Repligen Description and Business Overview
6.12.3 Repligen Histone Deacetylase (HDAC) Inhibitors Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Repligen Histone Deacetylase (HDAC) Inhibitors Product Portfolio
6.12.5 Repligen Recent Developments/Updates
6.13 TetraLogic
6.13.1 TetraLogic Company Information
6.13.2 TetraLogic Description and Business Overview
6.13.3 TetraLogic Histone Deacetylase (HDAC) Inhibitors Sales, Revenue and Gross Margin (2020-2025)
6.13.4 TetraLogic Histone Deacetylase (HDAC) Inhibitors Product Portfolio
6.13.5 TetraLogic Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Histone Deacetylase (HDAC) Inhibitors Industry Chain Analysis
7.2 Histone Deacetylase (HDAC) Inhibitors Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Histone Deacetylase (HDAC) Inhibitors Production Mode & Process Analysis
7.4 Histone Deacetylase (HDAC) Inhibitors Sales and Marketing
7.4.1 Histone Deacetylase (HDAC) Inhibitors Sales Channels
7.4.2 Histone Deacetylase (HDAC) Inhibitors Distributors
7.5 Histone Deacetylase (HDAC) Inhibitors Customer Analysis
8 Histone Deacetylase (HDAC) Inhibitors Market Dynamics
8.1 Histone Deacetylase (HDAC) Inhibitors Industry Trends
8.2 Histone Deacetylase (HDAC) Inhibitors Market Drivers
8.3 Histone Deacetylase (HDAC) Inhibitors Market Challenges
8.4 Histone Deacetylase (HDAC) Inhibitors Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
4SC AG
Acetylon Pharmaceuticals
Celleron Therapeutics
Chipscreen Biosciences
Chroma Therapeutics
CrystalGenomics Inc
Curis
MEI Pharma
Mirati Therapeutics
Novartis
Onxeo
Repligen
TetraLogic
List of Tables
 Table 1. Global Histone Deacetylase (HDAC) Inhibitors Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Histone Deacetylase (HDAC) Inhibitors Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Histone Deacetylase (HDAC) Inhibitors Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Histone Deacetylase (HDAC) Inhibitors Sales (MT) of Key Manufacturers (2020-2025)
 Table 5. Global Histone Deacetylase (HDAC) Inhibitors Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Histone Deacetylase (HDAC) Inhibitors Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Histone Deacetylase (HDAC) Inhibitors Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Histone Deacetylase (HDAC) Inhibitors Average Price (USD/MT) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Histone Deacetylase (HDAC) Inhibitors, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Histone Deacetylase (HDAC) Inhibitors, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Histone Deacetylase (HDAC) Inhibitors, Product Type & Application
 Table 12. Global Key Manufacturers of Histone Deacetylase (HDAC) Inhibitors, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Histone Deacetylase (HDAC) Inhibitors by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Histone Deacetylase (HDAC) Inhibitors as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Histone Deacetylase (HDAC) Inhibitors Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Histone Deacetylase (HDAC) Inhibitors Sales by Region (2020-2025) & (MT)
 Table 18. Global Histone Deacetylase (HDAC) Inhibitors Sales Market Share by Region (2020-2025)
 Table 19. Global Histone Deacetylase (HDAC) Inhibitors Sales by Region (2026-2031) & (MT)
 Table 20. Global Histone Deacetylase (HDAC) Inhibitors Sales Market Share by Region (2026-2031)
 Table 21. Global Histone Deacetylase (HDAC) Inhibitors Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Histone Deacetylase (HDAC) Inhibitors Revenue Market Share by Region (2020-2025)
 Table 23. Global Histone Deacetylase (HDAC) Inhibitors Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Histone Deacetylase (HDAC) Inhibitors Revenue Market Share by Region (2026-2031)
 Table 25. North America Histone Deacetylase (HDAC) Inhibitors Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Histone Deacetylase (HDAC) Inhibitors Sales by Country (2020-2025) & (MT)
 Table 27. North America Histone Deacetylase (HDAC) Inhibitors Sales by Country (2026-2031) & (MT)
 Table 28. North America Histone Deacetylase (HDAC) Inhibitors Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Histone Deacetylase (HDAC) Inhibitors Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Histone Deacetylase (HDAC) Inhibitors Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Histone Deacetylase (HDAC) Inhibitors Sales by Country (2020-2025) & (MT)
 Table 32. Europe Histone Deacetylase (HDAC) Inhibitors Sales by Country (2026-2031) & (MT)
 Table 33. Europe Histone Deacetylase (HDAC) Inhibitors Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Histone Deacetylase (HDAC) Inhibitors Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Histone Deacetylase (HDAC) Inhibitors Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Histone Deacetylase (HDAC) Inhibitors Sales by Region (2020-2025) & (MT)
 Table 37. Asia Pacific Histone Deacetylase (HDAC) Inhibitors Sales by Region (2026-2031) & (MT)
 Table 38. Asia Pacific Histone Deacetylase (HDAC) Inhibitors Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Histone Deacetylase (HDAC) Inhibitors Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Histone Deacetylase (HDAC) Inhibitors Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Histone Deacetylase (HDAC) Inhibitors Sales by Country (2020-2025) & (MT)
 Table 42. Latin America Histone Deacetylase (HDAC) Inhibitors Sales by Country (2026-2031) & (MT)
 Table 43. Latin America Histone Deacetylase (HDAC) Inhibitors Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Histone Deacetylase (HDAC) Inhibitors Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Histone Deacetylase (HDAC) Inhibitors Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Histone Deacetylase (HDAC) Inhibitors Sales by Country (2020-2025) & (MT)
 Table 47. Middle East and Africa Histone Deacetylase (HDAC) Inhibitors Sales by Country (2026-2031) & (MT)
 Table 48. Middle East and Africa Histone Deacetylase (HDAC) Inhibitors Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Histone Deacetylase (HDAC) Inhibitors Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Histone Deacetylase (HDAC) Inhibitors Sales (MT) by Type (2020-2025)
 Table 51. Global Histone Deacetylase (HDAC) Inhibitors Sales (MT) by Type (2026-2031)
 Table 52. Global Histone Deacetylase (HDAC) Inhibitors Sales Market Share by Type (2020-2025)
 Table 53. Global Histone Deacetylase (HDAC) Inhibitors Sales Market Share by Type (2026-2031)
 Table 54. Global Histone Deacetylase (HDAC) Inhibitors Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Histone Deacetylase (HDAC) Inhibitors Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Histone Deacetylase (HDAC) Inhibitors Revenue Market Share by Type (2020-2025)
 Table 57. Global Histone Deacetylase (HDAC) Inhibitors Revenue Market Share by Type (2026-2031)
 Table 58. Global Histone Deacetylase (HDAC) Inhibitors Price (USD/MT) by Type (2020-2025)
 Table 59. Global Histone Deacetylase (HDAC) Inhibitors Price (USD/MT) by Type (2026-2031)
 Table 60. Global Histone Deacetylase (HDAC) Inhibitors Sales (MT) by Application (2020-2025)
 Table 61. Global Histone Deacetylase (HDAC) Inhibitors Sales (MT) by Application (2026-2031)
 Table 62. Global Histone Deacetylase (HDAC) Inhibitors Sales Market Share by Application (2020-2025)
 Table 63. Global Histone Deacetylase (HDAC) Inhibitors Sales Market Share by Application (2026-2031)
 Table 64. Global Histone Deacetylase (HDAC) Inhibitors Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Histone Deacetylase (HDAC) Inhibitors Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Histone Deacetylase (HDAC) Inhibitors Revenue Market Share by Application (2020-2025)
 Table 67. Global Histone Deacetylase (HDAC) Inhibitors Revenue Market Share by Application (2026-2031)
 Table 68. Global Histone Deacetylase (HDAC) Inhibitors Price (USD/MT) by Application (2020-2025)
 Table 69. Global Histone Deacetylase (HDAC) Inhibitors Price (USD/MT) by Application (2026-2031)
 Table 70. 4SC Company Information
 Table 71. 4SC Description and Business Overview
 Table 72. 4SC Histone Deacetylase (HDAC) Inhibitors Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 73. 4SC Histone Deacetylase (HDAC) Inhibitors Product
 Table 74. 4SC Recent Developments/Updates
 Table 75. Acetylon Pharmaceuticals Company Information
 Table 76. Acetylon Pharmaceuticals Description and Business Overview
 Table 77. Acetylon Pharmaceuticals Histone Deacetylase (HDAC) Inhibitors Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 78. Acetylon Pharmaceuticals Histone Deacetylase (HDAC) Inhibitors Product
 Table 79. Acetylon Pharmaceuticals Recent Developments/Updates
 Table 80. Celleron Therapeutics Company Information
 Table 81. Celleron Therapeutics Description and Business Overview
 Table 82. Celleron Therapeutics Histone Deacetylase (HDAC) Inhibitors Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 83. Celleron Therapeutics Histone Deacetylase (HDAC) Inhibitors Product
 Table 84. Celleron Therapeutics Recent Developments/Updates
 Table 85. Chipscreen Biosciences Company Information
 Table 86. Chipscreen Biosciences Description and Business Overview
 Table 87. Chipscreen Biosciences Histone Deacetylase (HDAC) Inhibitors Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 88. Chipscreen Biosciences Histone Deacetylase (HDAC) Inhibitors Product
 Table 89. Chipscreen Biosciences Recent Developments/Updates
 Table 90. Chroma Therapeutics Company Information
 Table 91. Chroma Therapeutics Description and Business Overview
 Table 92. Chroma Therapeutics Histone Deacetylase (HDAC) Inhibitors Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 93. Chroma Therapeutics Histone Deacetylase (HDAC) Inhibitors Product
 Table 94. Chroma Therapeutics Recent Developments/Updates
 Table 95. CrystalGenomics Company Information
 Table 96. CrystalGenomics Description and Business Overview
 Table 97. CrystalGenomics Histone Deacetylase (HDAC) Inhibitors Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 98. CrystalGenomics Histone Deacetylase (HDAC) Inhibitors Product
 Table 99. CrystalGenomics Recent Developments/Updates
 Table 100. Curis Company Information
 Table 101. Curis Description and Business Overview
 Table 102. Curis Histone Deacetylase (HDAC) Inhibitors Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 103. Curis Histone Deacetylase (HDAC) Inhibitors Product
 Table 104. Curis Recent Developments/Updates
 Table 105. MEI Pharma Company Information
 Table 106. MEI Pharma Description and Business Overview
 Table 107. MEI Pharma Histone Deacetylase (HDAC) Inhibitors Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 108. MEI Pharma Histone Deacetylase (HDAC) Inhibitors Product
 Table 109. MEI Pharma Recent Developments/Updates
 Table 110. Mirati Therapeutics Company Information
 Table 111. Mirati Therapeutics Description and Business Overview
 Table 112. Mirati Therapeutics Histone Deacetylase (HDAC) Inhibitors Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 113. Mirati Therapeutics Histone Deacetylase (HDAC) Inhibitors Product
 Table 114. Mirati Therapeutics Recent Developments/Updates
 Table 115. Novartis Company Information
 Table 116. Novartis Description and Business Overview
 Table 117. Novartis Histone Deacetylase (HDAC) Inhibitors Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 118. Novartis Histone Deacetylase (HDAC) Inhibitors Product
 Table 119. Novartis Recent Developments/Updates
 Table 120. Onxeo Company Information
 Table 121. Onxeo Description and Business Overview
 Table 122. Onxeo Histone Deacetylase (HDAC) Inhibitors Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 123. Onxeo Histone Deacetylase (HDAC) Inhibitors Product
 Table 124. Onxeo Recent Developments/Updates
 Table 125. Repligen Company Information
 Table 126. Repligen Description and Business Overview
 Table 127. Repligen Histone Deacetylase (HDAC) Inhibitors Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 128. Repligen Histone Deacetylase (HDAC) Inhibitors Product
 Table 129. Repligen Recent Developments/Updates
 Table 130. TetraLogic Company Information
 Table 131. TetraLogic Description and Business Overview
 Table 132. TetraLogic Histone Deacetylase (HDAC) Inhibitors Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 133. TetraLogic Histone Deacetylase (HDAC) Inhibitors Product
 Table 134. TetraLogic Recent Developments/Updates
 Table 135. Key Raw Materials Lists
 Table 136. Raw Materials Key Suppliers Lists
 Table 137. Histone Deacetylase (HDAC) Inhibitors Distributors List
 Table 138. Histone Deacetylase (HDAC) Inhibitors Customers List
 Table 139. Histone Deacetylase (HDAC) Inhibitors Market Trends
 Table 140. Histone Deacetylase (HDAC) Inhibitors Market Drivers
 Table 141. Histone Deacetylase (HDAC) Inhibitors Market Challenges
 Table 142. Histone Deacetylase (HDAC) Inhibitors Market Restraints
 Table 143. Research Programs/Design for This Report
 Table 144. Key Data Information from Secondary Sources
 Table 145. Key Data Information from Primary Sources
 Table 146. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Histone Deacetylase (HDAC) Inhibitors
 Figure 2. Global Histone Deacetylase (HDAC) Inhibitors Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Histone Deacetylase (HDAC) Inhibitors Market Share by Type: 2024 & 2031
 Figure 4. Fatty Acid Product Picture
 Figure 5. Hydroxamate Product Picture
 Figure 6. Cyclic Peptide Product Picture
 Figure 7. Benzamide Product Picture
 Figure 8. Global Histone Deacetylase (HDAC) Inhibitors Market Value by Application (2020-2031) & (US$ Million)
 Figure 9. Global Histone Deacetylase (HDAC) Inhibitors Market Share by Application: 2024 & 2031
 Figure 10. Treatment of Malignant Tumors
 Figure 11. Chronic Disease Treatment
 Figure 12. Others
 Figure 13. Global Histone Deacetylase (HDAC) Inhibitors Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 14. Global Histone Deacetylase (HDAC) Inhibitors Market Size (2020-2031) & (US$ Million)
 Figure 15. Global Histone Deacetylase (HDAC) Inhibitors Sales (2020-2031) & (MT)
 Figure 16. Global Histone Deacetylase (HDAC) Inhibitors Average Price (USD/MT) & (2020-2031)
 Figure 17. Histone Deacetylase (HDAC) Inhibitors Report Years Considered
 Figure 18. Histone Deacetylase (HDAC) Inhibitors Sales Share by Manufacturers in 2024
 Figure 19. Global Histone Deacetylase (HDAC) Inhibitors Revenue Share by Manufacturers in 2024
 Figure 20. Global 5 and 10 Largest Histone Deacetylase (HDAC) Inhibitors Players: Market Share by Revenue in Histone Deacetylase (HDAC) Inhibitors in 2024
 Figure 21. Histone Deacetylase (HDAC) Inhibitors Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 22. Global Histone Deacetylase (HDAC) Inhibitors Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 23. North America Histone Deacetylase (HDAC) Inhibitors Sales Market Share by Country (2020-2031)
 Figure 24. North America Histone Deacetylase (HDAC) Inhibitors Revenue Market Share by Country (2020-2031)
 Figure 25. U.S. Histone Deacetylase (HDAC) Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Canada Histone Deacetylase (HDAC) Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. Europe Histone Deacetylase (HDAC) Inhibitors Sales Market Share by Country (2020-2031)
 Figure 28. Europe Histone Deacetylase (HDAC) Inhibitors Revenue Market Share by Country (2020-2031)
 Figure 29. Germany Histone Deacetylase (HDAC) Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. France Histone Deacetylase (HDAC) Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. U.K. Histone Deacetylase (HDAC) Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Italy Histone Deacetylase (HDAC) Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Russia Histone Deacetylase (HDAC) Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Asia Pacific Histone Deacetylase (HDAC) Inhibitors Sales Market Share by Region (2020-2031)
 Figure 35. Asia Pacific Histone Deacetylase (HDAC) Inhibitors Revenue Market Share by Region (2020-2031)
 Figure 36. China Histone Deacetylase (HDAC) Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Japan Histone Deacetylase (HDAC) Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. South Korea Histone Deacetylase (HDAC) Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. India Histone Deacetylase (HDAC) Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Australia Histone Deacetylase (HDAC) Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Taiwan Histone Deacetylase (HDAC) Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Indonesia Histone Deacetylase (HDAC) Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Thailand Histone Deacetylase (HDAC) Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Malaysia Histone Deacetylase (HDAC) Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Philippines Histone Deacetylase (HDAC) Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Latin America Histone Deacetylase (HDAC) Inhibitors Sales Market Share by Country (2020-2031)
 Figure 47. Latin America Histone Deacetylase (HDAC) Inhibitors Revenue Market Share by Country (2020-2031)
 Figure 48. Mexico Histone Deacetylase (HDAC) Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Brazil Histone Deacetylase (HDAC) Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Argentina Histone Deacetylase (HDAC) Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Middle East and Africa Histone Deacetylase (HDAC) Inhibitors Sales Market Share by Country (2020-2031)
 Figure 52. Middle East and Africa Histone Deacetylase (HDAC) Inhibitors Revenue Market Share by Country (2020-2031)
 Figure 53. Turkey Histone Deacetylase (HDAC) Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Saudi Arabia Histone Deacetylase (HDAC) Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. U.A.E Histone Deacetylase (HDAC) Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 56. Global Sales Market Share of Histone Deacetylase (HDAC) Inhibitors by Type (2020-2031)
 Figure 57. Global Revenue Market Share of Histone Deacetylase (HDAC) Inhibitors by Type (2020-2031)
 Figure 58. Global Histone Deacetylase (HDAC) Inhibitors Price (USD/MT) by Type (2020-2031)
 Figure 59. Global Sales Market Share of Histone Deacetylase (HDAC) Inhibitors by Application (2020-2031)
 Figure 60. Global Revenue Market Share of Histone Deacetylase (HDAC) Inhibitors by Application (2020-2031)
 Figure 61. Global Histone Deacetylase (HDAC) Inhibitors Price (USD/MT) by Application (2020-2031)
 Figure 62. Histone Deacetylase (HDAC) Inhibitors Value Chain
 Figure 63. Channels of Distribution (Direct Vs Distribution)
 Figure 64. Bottom-up and Top-down Approaches for This Report
 Figure 65. Data Triangulation
 Figure 66. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Accenture

SIMILAR REPORTS

Global HDAC histone deacetylase Inhibitor Market Insights Forecast to 2030
Global Histone Deacetylase 3 Market Research Report 2025
Global HDAC8 Antibody Market Research Report 2024
Global Trichostatin A Market Research Report 2024
Global PD 1 Inhibitor Market Research Report 2024
HDAC1 ELISA Kit Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global EZH2 Inhibitor Market Research Report 2024
Global Romidepsin Market Research Report 2024
Global Valproic Acid Market Research Report 2025
Global Histone Modified Antibody Market Research Report 2025
Global Epigenetic Therapeutics Market Research Report 2024
Global Histone Deacetylase 1 HDAC1 Antibody Market Research Report 2024
Global Anti hair Loss and Growth Products Market Research Report 2025
Global Vorinostat Market Research Report 2024
JAK1 Inhibitors Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Histone Deacetylase Inhibitors Market Research Report 2025
Global FAP Inhibitor Market Research Report 2024
Global Artificial Sweeteners Market Research Report 2024
Global Histone Methyltransferases Market Research Report 2024
Global 14 Alpha Demethylase Inhibitor Market Research Report 2025

RELATED REPORTS

Global Salt Active Nuclease Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-6W17226
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Ecology Products Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-29H6022
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Robotics Paint Booth Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3R7922
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Parietal Bone Model Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-34V19460
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions